Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
 - EconoTimes)
NEW ORLEANS, Oct. 10, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 16, 2017 to file lead plaintiff applications in a securities class action lawsuit against Rayonier Advanced Materials, Inc. (NYSE:RYAM), if they purchased the Company’s shares between October 29, 2014 and August 19, 2015, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.
Get Help
Rayonier investors should visit us at https://www.claimsfiler.com/cases/new-york-se-ryam or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Rayonier and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
Since 2013, despite statements by the Company to the contrary, Rayonier had been experiencing ongoing difficulties with one of its top customers, Eastman Chemical Company (“Eastman”), regarding competitive pricing levels and certain terms of the contract between the companies. Finally, on August 19, 2015, Rayonier revealed the extent of the protracted dispute with Eastman, including that it had filed suit against it the prior week.
On this news, the price of Rayonier shares plummeted 44% to close at $7.62 on extremely heavy trading volume.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
